Tapasin-related protein is a T cell co-inhibitory molecule identified in 2021 (Lin et al., 2021), which is expressed on cancer cells and antigen-presenting cells as well as the corresponding receptor on activated CD4 and CD8 T cells. Here, TAPBPL is linked to cancer.